Kovo HealthTech Corp.

  • Market Cap: Micro Cap
  • Industry: Computers - Software & Consulting
  • ISIN: CA50073R1073
CAD
0.03
0.01 (25.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Operating profit has grown by an annual rate -183.26% of over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
2

The company has declared negative results for the last 7 consecutive quarters

3

Risky -

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Computers - Software & Consulting

stock-summary
Market cap

CAD 6 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-2.83

stock-summary
Return on Equity

108.70%

stock-summary
Price to Book

-0.90

Revenue and Profits:
Net Sales:
4 Million
(Quarterly Results - Jun 2025)
Net Profit:
-2 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-37.5%
0%
-37.5%
6 Months
-58.33%
0%
-58.33%
1 Year
0%
0%
0.0%
2 Years
-79.17%
0%
-79.17%
3 Years
-83.33%
0%
-83.33%
4 Years
-97.06%
0%
-97.06%
5 Years
0%
0%
0.0%

Kovo HealthTech Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
35.76%
EBIT Growth (5y)
-183.26%
EBIT to Interest (avg)
-1.62
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-3.44
Sales to Capital Employed (avg)
1.42
Tax Ratio
7.18%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-1.29
EV to EBIT
-6.36
EV to EBITDA
-9.27
EV to Capital Employed
2.25
EV to Sales
1.88
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-35.44%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.00% vs -2.50% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -6.25% vs 20.00% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.90",
          "val2": "3.90",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.10",
          "val2": "-0.40",
          "chgp": "75.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.30",
          "val2": "0.90",
          "chgp": "44.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.70",
          "val2": "-1.60",
          "chgp": "-6.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-120.50%",
          "val2": "-196.10%",
          "chgp": "7.56%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 7.41% vs -1.46% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -26.98% vs -2,000.00% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14.50",
          "val2": "13.50",
          "chgp": "7.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.20",
          "val2": "-3.70",
          "chgp": "13.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.90",
          "val2": "0.80",
          "chgp": "387.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.30",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-8.00",
          "val2": "-6.30",
          "chgp": "-26.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-307.10%",
          "val2": "-351.90%",
          "chgp": "4.48%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
3.90
3.90
Operating Profit (PBDIT) excl Other Income
-0.10
-0.40
75.00%
Interest
1.30
0.90
44.44%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.70
-1.60
-6.25%
Operating Profit Margin (Excl OI)
-120.50%
-196.10%
7.56%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 0.00% vs -2.50% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -6.25% vs 20.00% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
14.50
13.50
7.41%
Operating Profit (PBDIT) excl Other Income
-3.20
-3.70
13.51%
Interest
3.90
0.80
387.50%
Exceptional Items
0.00
-0.30
100.00%
Consolidate Net Profit
-8.00
-6.30
-26.98%
Operating Profit Margin (Excl OI)
-307.10%
-351.90%
4.48%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 7.41% vs -1.46% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -26.98% vs -2,000.00% in Dec 2023

stock-summaryCompany CV
About Kovo HealthTech Corp. stock-summary
stock-summary
Kovo HealthTech Corp.
Computers - Software & Consulting
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available